Hjem › Prostatakreft › Wisconsin › Madison
Kliniske studier for Prostatakreft i Madison, WI
29 studier for Prostatakreft søker deltakere på steder i og rundt Madison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- University of Wisconsin Carbone Cancer Center, Madison
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekruttererFase 3
- William S Middleton VA Medical Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
PET/CT Characterization of Treatment Resistance
Rekrutterer
- University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RekruttererFase 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RekruttererFase 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RekruttererFase 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekruttererFase 3
- University Hospital and UW Health Clinics ( Site 0065), Madison
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
RekruttererFase 2
- Carbone Cancer Center University of Wisconsin-Madison, Madison
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RekruttererFase 3
- University of Wisconsin, Madison
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruttererFase 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
RekruttererFase 2
- UW Health Carbone Cancer Center, Madison
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
RekruttererObservasjonsstudie
- University of Wisconsin Carbone Cancer Center, Madison
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
RekruttererFase 2
- University of Wisconsin Carbone Cancer Center-Madison, Madison
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekruttererFase 3
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RekruttererFase 1
- University of Wisconsin Carbone Cancer Center, Madison
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
RekruttererObservasjonsstudie
- University of Wisconsin-Madison, Madison
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruttererFase 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
RekruttererFase 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekruttererFase 1
- University of Wisconsin, Madison
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RekruttererFase 1
- University of Wisconsin Carbone Cancer Center, Madison
Using FAPI PET/MRI to Evaluate Prostate Cancer
RekruttererFase 2
- University of Wisconsin, Madison
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RekruttererObservasjonsstudie
- University of Wisconsin Carbone Cancer Center, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekruttererFase 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
RekruttererFase 1
- University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
RekruttererFase 1
- University of Wisconsin - Madison, Madison
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekruttererFase 4
- University of Wisconsin, Madison
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
RekruttererObservasjonsstudie
- University of Wisconsin-Madison, Madison
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Madison
- Kolorektal kreft22 studier
- Brystkreft22 studier
- Metastatisk kreft21 studier
- Ikke-småcellet lungekreft16 studier
- Akut myelogen leukemi16 studier
- Melanom15 studier
- Kreft (alle typer)14 studier
- Eggstokkreft13 studier
- Mavekreft11 studier
- Lungekreft10 studier
- Pankreaskreft10 studier
- Multipelt myelom9 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.